1. Home
  2. RLMD vs MCI Comparison

RLMD vs MCI Comparison

Compare RLMD & MCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

SELL

Current Price

$3.06

Market Cap

348.8M

Sector

Health Care

ML Signal

SELL

Logo Barings Corporate Investors

MCI

Barings Corporate Investors

SELL

Current Price

$17.16

Market Cap

378.5M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
RLMD
MCI
Founded
2004
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
348.8M
378.5M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
RLMD
MCI
Price
$3.06
$17.16
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
★ $10.75
N/A
AVG Volume (30 Days)
★ 1.7M
31.4K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 8.46%
EPS Growth
★ 45.28
N/A
EPS
N/A
★ 1.82
Revenue
★ $13,070.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$9.98
Revenue Growth
★ 154.83
N/A
52 Week Low
$3.07
$16.21
52 Week High
$8.00
$21.33

Technical Indicators

Market Signals
Indicator
RLMD
MCI
Relative Strength Index (RSI) 37.32 45.33
Support Level N/A $17.28
Resistance Level $3.55 $18.18
Average True Range (ATR) 0.43 0.44
MACD -0.04 0.08
Stochastic Oscillator 4.05 39.52

Price Performance

Historical Comparison
RLMD
MCI

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

About MCI Barings Corporate Investors

Barings Corporate Investors is a closed-end management investment company. Its investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. The Trust's principal investments are privately placed, below-investment grade, long-term debt obligations, including bank loans and mezzanine debt instruments. The Trust typically purchases these investments, which are not publicly tradable, directly from their issuers in private placement transactions, and the investments are typically made to small or middle market companies.

Share on Social Networks: